Antibody-Mediated BRCC36 Silencing: A Novel Approach for Targeted Breast Cancer Therapy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  2009-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.21236/ada513475
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control.

  2009cited by this paper
• MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks.

  2009cited by this paper
• AZD2281 (KU-0059436), a PARP (poly ADP-ribose polymerase) inhibitor with single agent anticancer activity in patients with BRCA deficient ovarian cancer: Results from a phase I study

  2008cited by this paper
• RAP80 responds to DNA damage induced by both ionizing radiation and UV irradiation and is phosphorylated at Ser 205.

  2008cited by this paper
• Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk.

  2008cited by this paper
• Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response

  2007cited by this paper
• CCDC98 targets BRCA1 to DNA damage sites

  2007cited by this paper
• BRCA1 ubiquitinates RPB8 in response to DNA damage.

  2007cited by this paper
• CCDC98 is a BRCA1-BRCT domain–binding protein involved in the DNA damage response

  2007cited by this paper
• Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage

  2007cited by this paper
• BRCA1 promoter deletions in young women with breast cancer and a strong family history: a population-based study.

  2007cited by this paper
• RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites

  2007cited by this paper
• Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1

  2007cited by this paper
• First in human phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of KU-0059436 (Ku), a small molecule inhibitor of poly ADP-ribose polymerase (PARP) in cancer patients (p), including BRCA1/2 mutation carriers

  2007cited by this paper
• Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome.

  2007cited by this paper
• Current Development of Clinical Inhibitors of Poly(ADP-Ribose) Polymerase in Oncology

  2007cited by this paper
• Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials

  2007cited by this paper
• Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

  2006cited by this paper
• The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populations

  2006cited by this paper
• MicroRNAs direct rapid deadenylation of mRNA.

  2006cited by this paper
• BRCC36 is essential for ionizing radiation-induced BRCA1 phosphorylation and nuclear foci formation.

  2006cited by this paper
• Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression

  2006cited by this paper
• BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance

  2006cited by this paper
• Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling

  2006cited by this paper
• Oncomirs — microRNAs with a role in cancer

  2006cited by this paper
• Family History, and Impact on Clinical Presentation and Prognosis, in a Population-based Breast Cancer Cohort from the Stockholm County

  2006cited by this paper
• BRCA1/BARD1 Ubiquitinate Phosphorylated RNA Polymerase II*

  2005influential reference
• MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence

  2005cited by this paper
• Prevalence of BRCA Mutations and Founder Effect in High-Risk Hispanic Families

  2005cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• The roles of BRCA1 and BRCA2 in the cellular response to ionizing radiation.

  2005cited by this paper
• Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining.

  2005cited by this paper
• Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors

  2005cited by this paper
• Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

  2005cited by this paper
• BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II.

  2005cited by this paper
• Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: Public health implications

  2005cited by this paper
• Modulation of radiation response by histone deacetylase inhibition.

  2005cited by this paper
• BRCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study

  2005cited by this paper
• RNA interference in adult mice

  2005cited by this paper
• Allele-specific gene expression differences in humans.

  2004cited by this paper
• Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene

  2004cited by this paper
• BRCA1/BARD1 orthologs required for DNA repair in Caenorhabditis elegans.

  2004cited by this paper
• Nucleophosmin/B23 Is a Candidate Substrate for the BRCA1-BARD1 Ubiquitin Ligase*

  2004cited by this paper
• Human Rad51C Deficiency Destabilizes XRCC3, Impairs Recombination, and Radiosensitizes S/G2-phase Cells*

  2004cited by this paper
• Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers

  2004cited by this paper
• The role of BRCA1 in the cellular response to chemotherapy.

  2004cited by this paper
• Differing effects of breast cancer 1, early onset (BRCA1) and ataxia‐telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation

  2003cited by this paper
• Loss of Bard1, the Heterodimeric Partner of the Brca1 Tumor Suppressor, Results in Early Embryonic Lethality and Chromosomal Instability

  2003cited by this paper
• Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.

  2003cited by this paper
• Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.

  2003cited by this paper
• Allelic variation in gene expression is common in the human genome.

  2003cited by this paper
• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  2003cited by this paper
• Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

  2003influential reference
• Prognostic significance of BRCA1 expression in sporadic breast carcinomas

  2003cited by this paper
• Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair.

  2003cited by this paper
• Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

  2002cited by this paper
• Quantification of single nucleotide polymorphisms: A novel method that combines primer extension assay and capillary electrophoresis

  2002cited by this paper
• Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.

  2002cited by this paper
• Poly(ADP-ribose) Polymerase-2 (PARP-2) Is Required for Efficient Base Excision DNA Repair in Association with PARP-1 and XRCC1*

  2002cited by this paper
• Breast cancer: Prognosis, Treatment and Prevention Published in July 2002 by Marcel Dekker Inc., New York, USA; Basel, Switzerland; 656 pages; ISBN: 0-8247-0712-5; US$ 165.00

  2002cited by this paper
• Inactivation of BRCA1 and BRCA2 in ovarian cancer.

  2002cited by this paper
• Lack of functional pRb results in attenuated recovery of mRNA synthesis and increased apoptosis following UV radiation in human breast cancer cells

  2002cited by this paper
• BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage

  2002cited by this paper
• Interaction of FANCD2 and NBS1 in the DNA damage response

  2002cited by this paper
• Small changes in expression affect predisposition to tumorigenesis

  2002cited by this paper
• Real-Time Quantitative PCR

  2002cited by this paper
• SV40 large T-antigen disturbs the formation of nuclear DNA-repair foci containing MRE11

  2002cited by this paper
• Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.

  2002cited by this paper
• Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent with BRCA1:ψBRCA1 recombination

  2002cited by this paper
• Homologous repair of DNA damage and tumorigenesis:the BRCA connection

  2002cited by this paper
• Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation

  2002cited by this paper
• Allelic Variation in Human Gene Expression

  2002influential reference
• Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity

  2001influential reference
• Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

  2001cited by this paper
• Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

  2001cited by this paper
• Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis

  2001influential reference
• Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1

  2001cited by this paper
• Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells

  2001cited by this paper
• A somatic mutation in the 5′UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency

  2001cited by this paper
• Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas

  2001cited by this paper
• Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining

  2001cited by this paper
• Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.

  2001cited by this paper
• Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers

  2000cited by this paper
• BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

  2000influential reference
• Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations.

  2000cited by this paper
• BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

  2000cited by this paper
• BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer.

  2000cited by this paper
• Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

  2000cited by this paper
• Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients.

  2000cited by this paper
• hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

  2000cited by this paper
• True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management.

  2000cited by this paper
• Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.

  1999cited by this paper
• Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

  1999influential reference
• BRCA1 interacts with components of the histone deacetylase complex.

  1999cited by this paper
• BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer

  1999cited by this paper
• BRCA1 Expression Restores Radiation Resistance in BRCA1-defective Cancer Cells through Enhancement of Transcription-coupled DNA Repair*

  1999cited by this paper
• Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2

  1999cited by this paper
• BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.

  1999cited by this paper
• Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene

  1999cited by this paper
• Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

  1999cited by this paper

• No citing papers are available for this paper.